PreScission Protease (PSP): Tag Cleavage Guide
2026-09-03
PreScission Protease (PSP) is an HRV 3C protease fusion enzyme for removing affinity tags from recombinant fusion proteins at a defined Gln-Gly junction. It is suited to controlled protein purification workflows, but not to constructs lacking the specified recognition sequence or applications requiring nonspecific proteolysis.
HyperScribe T7 High Yield RNA Synthesis Kit Plus Workflow
2026-09-02
Build high-yield RNA for mRNA rescue, labeled-probe assays, antisense studies, and RNA interference experiments from a linearized DNA template. The HyperScribe™ T7 High Yield RNA Synthesis Kit Plus combines a pre-supplemented T7 enzyme mix with flexible nucleotide options and scalable reaction capacity for reproducible research workflows.
Antipyrine in BBB Permeability Workflows
2026-09-02
Antipyrine combines high aqueous solubility with a defined chemical identity, making it a practical comparator for permeability, pharmacokinetic, and drug metabolism research. This workflow shows how to integrate it into LLC-PK1-MOCK/MDR1 Transwell assays while avoiding misleading conclusions from barrier failure or lysosomal trapping.
In Vitro Drug Response: Beyond Relative Viability
2026-09-01
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability to separate growth inhibition from actual cell killing in cancer drug-response studies. Its central implication is practical: dose–response experiments should measure both response dimensions and consider their timing rather than treating a single viability value as a complete pharmacologic phenotype.
IEM 1460: From AMPA Blockade to Assay Design
2026-09-01
IEM 1460 is a selective AMPA receptor blocker for dissecting fast glutamatergic signaling, excitotoxicity, and neuroprotection. This article translates findings from a recent IEM-1925 seizure study into practical assay-design principles while clearly separating evidence from workflow hypotheses.
Resiquimod (R-848) in Immune Assays
2026-08-31
Resiquimod (R-848) provides a practical way to activate TLR7/8 and quantify innate immune response modulation in cell, hydrogel, and tumor-ablation workflows. This guide connects stock preparation and assay controls with a thermal-protective chemo-immunomodulation strategy demonstrated in a recent preclinical study.
Digestive Transformations of Withania somnifera
2026-08-30
This 2026 study combines simulated gastrointestinal digestion with LC–MS/MS metabolomics and molecular networking to determine how Withania somnifera leaf and root extracts change before absorption. The results distinguish labile constituents, including withaferin A and withanoside IV, from the comparatively stable withanolide A and root-extract withanolides, providing a more realistic framework for evaluating botanical bioavailability.
MEG3, NiO Nanoparticles, and Pulmonary Fibrosis
2026-08-29
The reference study identifies lncRNA MEG3 as a protective regulator in nickel oxide nanoparticle-induced pulmonary fibrosis and connects its loss to TGF-β1-dependent PI3K/AKT activation. Using rat and A549 cell models, the authors combine exposure experiments, pharmacologic inhibition, fibrosis markers, and MEG3 overexpression to define a mechanistic pathway relevant to nanotoxicology.
Nutlin-3a: MDM2 Inhibitor for p53 Research
2026-08-29
Nutlin-3a is a small-molecule MDM2 inhibitor that restores p53 signaling by blocking the MDM2 TP53-binding pocket. It is used in cancer research to study p53 pathway activation, cell cycle arrest, and apoptosis induction, with potency and handling parameters defined by product documentation and peer-reviewed pharmacology.
Recombinant Human Oncostatin M: Assay Workflows
2026-08-28
Build reproducible proliferation and cytokine-release experiments with a tag-free, low-endotoxin OSM preparation. This workflow also shows how rh-Oncostatin M can be evaluated as a controlled cytokine variable alongside lipid-remodeling and radioresistance assays without overstating what current evidence proves.
Protease Inhibitors Rewire Light-Induced Stomatal Opening
2026-08-28
Wang and colleagues developed a chemical screen showing that selected protease inhibitors suppress blue-light-induced stomatal opening in Commelina benghalensis. The strongest compounds reduced phosphorylation of the guard-cell plasma-membrane H+-ATPase without disrupting phototropin activity or ABA responses, identifying protease inhibition as a useful route for dissecting unresolved signaling steps.
Salvianolic acid B for Pulmonary Fibrosis
2026-08-27
Salvianolic acid B, also known as Dan Shen Suan B, gives fibrosis researchers a practical way to connect LH2 expression with collagen deposition, epithelial–mesenchymal transition, and matrix remodeling. This workflow emphasizes orthogonal readouts, fresh compound handling, and controls that separate antifibrotic signaling from nonspecific cytotoxicity.
DIDS: A Stress-Test Tool for Metastasis Biology
2026-08-27
DIDS, or 4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid, is more than a chloride transport probe. This article explains how its broad pharmacology can be used—and carefully controlled—to dissect cell-death-associated prometastatic states, mitochondrial permeabilization, and cross-domain ion-channel biology.
Erastin and the Final Phase of Ferroptosis
2026-08-26
Erastin is a ferroptosis inducer that exposes how redox collapse becomes irreversible plasma-membrane damage. This article connects Erastin assay design with new evidence on TMEM16F-mediated lipid scrambling, helping researchers distinguish pathway initiation from ferroptotic execution.
SB743921: KSP Inhibitor Workflow Guide
2026-08-26
SB743921 combines subnanomolar KSP potency with kinesin selectivity, making it useful for separating mitotic arrest from downstream cell death. This workflow pairs dose–response testing with time-resolved viability and apoptosis measurements to improve interpretation across cancer cell lines and tumor xenograft models.
483 records 8/33 page Previous Next First page 上5页 678910 下5页 Last page